Correlation of binding efficacies of DNA to flavonoids and their induced cellular damage

Journal of Photochemistry and Photobiology B: Biology

Volumn 170, Issue , 2017, Pages 256-262

  Das, Asmita ^a   Majumder, Debashis ^a   Saha, Chabita ^a  

^a MAULANA ABUL KALAM AZAD UNIVERSITY OF TECHNOLOGY   (India)

Author keywords

Antioxidant; Comet assay; Cytotoxicity; Drug interaction; Flavonoids

Indexed keywords

APIGENIN; DNA; KAEMPFEROL; LUTEOLIN; MYRICETIN; QUERCETIN; CALF THYMUS DNA; FLAVONOID; KAEMPFEROL DERIVATIVE;

ABSORPTION SPECTROSCOPY; ANTINEOPLASTIC ACTIVITY; ARTICLE; BINDING AFFINITY; CELL DAMAGE; CIRCULAR DICHROISM; COMET ASSAY; CONTROLLED STUDY; CYTOTOXICITY; DNA DAMAGE; DRUG DNA INTERACTION; HUMAN; HUMAN CELL; LEUKEMIA CELL; PRIORITY JOURNAL; ANIMAL; BOVINE; CHEMISTRY; DRUG EFFECTS; K-562 CELL LINE; METABOLISM; ULTRAVIOLET SPECTROPHOTOMETRY;

ANIMALS; APIGENIN; CATTLE; CIRCULAR DICHROISM; COMET ASSAY; DNA; DNA DAMAGE; FLAVONOIDS; HUMANS; K562 CELLS; KAEMPFEROLS; LUTEOLIN; QUERCETIN; SPECTROPHOTOMETRY, ULTRAVIOLET;

EID: 85018637873     PISSN: 10111344     EISSN: 18732682     Source Type: Journal    
DOI: 10.1016/j.jphotobiol.2017.04.019     Document Type: Article

References (25)

1. [1] Riboli, E., Norat, T., Epidemiologic evidence of the protective effect of fruit and vegetables on cancer risk 1,2,3,4. Am. J. Clin. Nutr. 78 (2003), 559S–569S.
2. [2] Batra, P., Sharma, A.K., Anti-cancer potential of flavonoids: recent trends and future perspectives. Biotech. 3 (2013), 439–459.
3. [3] Ren, W., Qiao, Z., Wang, H., Zhu, L., Zhang, L., Flavonoids: promising anticancer agents. Med. Res. Rev. 23 (2003), 519–534.
4. [4] Kanakis, C.D., Tarantilis, P.A., Polissiou, M.G., Diamantoglou, S., Tajmir-Riahi, H.A., DNA interaction with naturally occurring antioxidant flavonoids quercetin, kaempferol, and delphinidin. J. Biomol. Struct. Dyn. 22:6 (2005), 719–724.
5. [5] Sak, K., Cytotoxicity of dietary flavonoids on different human cancer types. Pharm. Rev. 8 (2014), 122–146.
6. [6] Liu, H.L., Jiang, W.B., Xie, M.X., Flavonoids: recent advances as anticancer drugs. Recent Pat. Anticancer Drug Discov. 5 (2010), 152–164.
7. [7] Chen, D., Wan, S.B., Yang, H., Yuan, J., Chan, T.H., Dou, Q.P., EGCG, green tea polyphenols and their synthetic analogs and pro drugs for human cancer prevention and treatment. Adv. Clin. Chem. 53 (2011), 155–177.
8. [8] Pietta, P.G., Flavonoids as antioxidants. J. Nat. Prod. 63 (2000), 1035–1042.
9. [9] William, R.J., Spencer, J.P., Rice-Evans, C., Flavonoids: antioxidants or signaling molecular?. Free Radic. Biol. Med. 36 (2004), 838–894.
10. [10] Cao, G., Sofic, E., Prior, R.L., Antioxidant and prooxidant behaviour of flavonoids: structure-activity relationships. Free Radic. Biol. Med. 22 (1997), 749–760.
11. [11] Pal, S., Dey, S.K., Saha, C., Inhibition of catalase by tea catechins in free and cellular state: a biophysical approach. PLoS One, 2014, 10.1371/journal.pone.0102460.
12. [12] Rietiens, I.M., Boersma, M.G., Haan, L.D., Spenkelink, B., Awad, H.M., Cnubben, N.H., Van Zanden, J.J., Woude, H.V., Alink, G.M., Koeman, J.H., The pro-oxidant chemistry of the natural antioxidants vitamin C, vitamin E, carotenoids and flavonoids. Environ. Toxicol. Pharmacol. 11 (2002), 321–333.
13. [13] Zhang, S., Yang, X., Morris, M.E., Combined effects of multiple flavonoids on breast cancer resistance protein (ABCG2)-mediated transport. Pharm. Res. 21 (2004), 1263–1273.
14. [14] Palchaudhuri, R., Hergenrother, P.J., DNA as a target for anticancer compounds: methods to determine the mode of binding and the mechanism of action. Curr. Opin. Biotechnol. 18 (2007), 497–503.
15. [15] Pal, S., Saha, C., A review on structure–affinity relationship of dietary flavonoids with serum albumins. J. Biomol. Struct. Dyn., 9, 2013, e102460.
16. [16] Ghosh, D., Hossain, M., Saha, C., Dey, S.K., Kumar, G.S., Intercalation and induction of strand breaks by adriamycin and daunomycin: a study with human genomic DNA. DNA Cell Biol. 31 (2012), 377–386.
17. [17] Sanjeev, R., Jagannadham, V., Veda, Vrath R., Implications of a novel interpretation of the isosbestic point. CiNZ 76 (2012), 133–135.
18. [18] Bao, T., Zhi-Feng, C., Zhi-Juan, L., Li-Yang, C., Yan-Jun, H., Understanding the structure–activity relationship between quercetin and naringenin. In Vitro RSC Adv. 5 (2015), 33058–33066.
19. [19] Jurasekova, Z., Domingo, C., Garcia-Ramos, J.V., Sanchez-Cortes, S., Effect of pH on the chemical modification of quercetin and structurally related flavonoids characterized by optical (UV–visible and Raman) spectroscopy. Phys. Chem. Chem. Phys. 16 (2014), 12802–12811.
20. [20] Gerweck, L.E., Seetharaman, K., Cellular pH gradient in tumor versus normal tissue: potential exploitation for the treatment of cancer. Cancer Res. 56 (1996), 1194–1198.
21. [21] Ahmed, M.S., Ramesh, V., Nagaraja, V., Parish, J.H., Hadi, S.M., Mode of binding of quercetin to DNA. Mutagenesis 3 (1994), 193–197.
22. [22] Kanakis, C.D., Nafisi, S.H., Rajabi, M., Shadaloi, A., Tarantilis, P.A., Polissiou, M.G., Bariyanga, J., Tajmir-Riahi, H.A., Structural analysis of DNA and RNA interactions with antioxidant flavonoids. Spectroscopy 23 (2009), 29–43.
23. [23] Tawani, A., Kumar, A., Structural insight into the interaction of flavonoids with human telomeric sequence. Sci. Rep., 5, 2015, 17574, 10.1038/srep17574.
24. [24] Hussain, A., Nida, R., Mohd, F., Aamir, A., Sheikh, M.H., Mobilization of copper ions by flavonoids in human peripheral lymphocytes leads to oxidative DNA breakage: a structure activity study. Int. J. Mol. Sci. 16 (2015), 26754–26769.
25. [25] Rahman, A., Shahabuddin, Hadi, S.M., Parish, J.H., Complexes involving quercetin, DNA and Cu (II). Carcinogenesis 11:11 (1990), 2001–2003.